Featured Research

from universities, journals, and other organizations

Hopkins Study Reveals Key Details On How We Get Energy

Date:
September 16, 1998
Source:
Johns Hopkins Medical Institutions
Summary:
Biochemists at Johns Hopkins report they have solved a major mystery surrounding the way most organisms -- including people -- get energy.

Biochemists at Johns Hopkins report they have solved a major mystery surrounding the way most organisms -- including people -- get energy. Their discovery, in this month's Proceedings of the National Academy of Sciences,caps decades of research on how cells make the common currency of energy, a molecule called ATP.

The Hopkins finding, which explains at the most fundamental level how energy from food ultimately yields ATP, also offers a new focus for studies about why most people get less energetic with age. The work was supported by NIH grants.

The research team led by L. Mario Amzel, Ph.D., and Peter Pedersen, Ph.D., used X-ray crystallography to reveal the molecular structure of adenosine triphosphate synthase, a dervish-like enzyme. Inside, the molecule whirls around several times a second while it triggers production of ATP. "It's one of the most complex molecules ever revealed, almost six times larger than the blood molecule hemoglobin," says Pedersen. It's also, the researchers agree, one of the tiniest and most powerful motors ever identified.

ATP synthase molecules are located within mitochondria, the oval- to bean-shaped structures scattered in cells and long known as the site of energy production. The molecules stick out on the mitochondria, attached to their inner surfaces in mushroom-like clusters.

When food is broken down or metabolized for energy, the last stages of the process occur within the mitochondria.

The ATP synthase molecule, has two parts. Recently, scientists in Japan discovered that one part, the "mushroom stem," apparently rotates within the "mushroom cap." Last year, a Nobel prize was awarded to the researcher (Paul Boyer, Ph.D., UCLA) who suggested that forming ATP was somehow tied to this rotation, and the prize was shared with another researcher (John Walker, Ph.D., Medical Research Council Laboratory, Cambridge, England) whose team laid out one of two possible structures for the "cap," which is believed to be short-lived.

In this new study, the Hopkins team determined the other structure, believed to be the most common form, in living organisms. The ATP synthase "mushroom cap," they found, contains three identical areas, arranged like a coil, where ATP is made. Each area is occupied with a different stage in ATP production.

As the "stem" rotates, it creates a powerful internal shifting in each of the three coiled sections within the cap. This shifting provides the energy to cause chemical changes. At one site, the "ingredients" for ATP come together. At another site, they assemble as ATP, and at the third site, the rotation readies the fully formed ATP to pop off the synthase molecule, for use throughout the cell.

The Hopkins team captured the image of the ATP synthase cap while all of its sites were in some stage of making ATP, which is essential for the constant recycling of its precursors. Without this recycling, Pedersen says, "people would have to produce more than half their body weight in ATP every day to meet their energy needs."

Some scientists have speculated that the same "free radicals" that damage skin in aging or cause mutations also might damage mitochondria. "If ATP synthase is a site of free radical damage, that could explain why we become less energetic with age," Pedersen says. Now that we know the molecular structures, we can pinpoint damaged regions if they occur."

Also on the research team were Mario A. Bianchet, Ph.D., and Joanne Hullihen.

--JHMI--

Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com and ScienceDaily at http://www.sciencedaily.com.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Hopkins Study Reveals Key Details On How We Get Energy." ScienceDaily. ScienceDaily, 16 September 1998. <www.sciencedaily.com/releases/1998/09/980915122233.htm>.
Johns Hopkins Medical Institutions. (1998, September 16). Hopkins Study Reveals Key Details On How We Get Energy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1998/09/980915122233.htm
Johns Hopkins Medical Institutions. "Hopkins Study Reveals Key Details On How We Get Energy." ScienceDaily. www.sciencedaily.com/releases/1998/09/980915122233.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins